Influence of Glycaemic Balance on the Ability of Apolipoprotein C1 to Inhibit Cholesteryl Ester Transfer Protein in Type-1 Diabetes Patients

Inclusion criteria for patients: * Patients over 18 years * Patients with type-1 diabetes and glycated hemoglobin (HbA1C) \>9% Inclusion criteria controls: * Subjects over 18 years * Normal glycaemia (Fasting glycaemia \<1.10 g/L) and normal lipids (Low-density lipoproteins (LDL) \<1.6 g/L, triglycerides (TG) \<1.5 g/L) Exclusion Criteria: Exclusion criteria patients: * Adults under guardianship * Patients without national health insurance * Pregnant or breast-feeding women * Progressive cancer * Treatment able to influence lipoprotein metabolism (oestroprogestatives, immunosuppressants, long-term corticotherapy) Exclusion criteria controls: * Adults under guardianship * Persons without national health insurance * Pregnant or breast-feeding women * known dyslipidemia and/or lipid-lowering treatment * Treatment able to influence lipoprotein metabolism (oestroprogestatives, immunosuppressants, long-term corticotherapy)